Xbrane Biopharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Scheeles Väg 5, Solna, Stockholm, 171 65...Phone Number
+46 738535802Website
www.xbrane.comRevenue
$28.1 MillionStock Symbol
XBRANEIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Xbrane Biopharma
Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. The company offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including wet form of age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and visual impairment due to cordial neovascularization in adults; and XB003, a biosimilar candidate to certolizumab pegol for the treatment of rheumatoid arthritis, psoriasis, Crohn's disease and axial spondylitis.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xbrane Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Xbrane Biopharma recently announced quarterly report
Funding: Get notified immidiatlly once Xbrane Biopharma has new funding data
Product Launch: Get notified when Xbrane Biopharma launches new products
Check if Xbrane Biopharma has recently received funding, and reach out quickly before it becomes old news!
Xbrane Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Xbrane Biopharma is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Xbrane Biopharma
Click to see if Xbrane Biopharma had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Xbrane Biopharma
Find 3 more new buyers
Company Profile Activity
Activity Insights
Xbrane Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xbrane Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xbrane Biopharma.
Xbrane Biopharma financials insights
Gather financial insights about Xbrane Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$6.3M
Xbrane Biopharma Tech Stack
A closer look at the technologies used by Xbrane Biopharma
See more technologies
Xbrane Biopharma News & Media
Xbrane Biopharma Secures Conditional Financing Amid FDA Approval Anticipation
The latest update is out from Xbrane Biopharma AB ( ($SE:XBRANE) ). Xbrane Biopharma has entered into a conditional financing agreement with Fenja Capital II A/S to...Alvotech Acquires Xbrane’s R&D Operations in Sweden
Alvotech (NASDAQ: ALVO), a Reykjavik, Iceland-based biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, acquired Xbrane’s R&D operations and the biosimilar candidate XB003. The purchase price for the acquisition was approximately SEK 275M (approximately USD 27M) and will be payable as SEK 102.2M in cash at closing and by […] The post Alvotech Acquires Xbrane’s R&D Operations in Sweden appeared first on FinSMEs.Xbrane Biopharma AB (STU:7XB) Q3 2024 Earnings Call Highlights: - GuruFocus
Xbrane Biopharma AB (STU:7XB) reports solid growth in Ximluci volumes and successful cost-saving measures, despite facing revenue mix challenges and FDA hurdles.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Xbrane Biopharma
Sign Up For FreeTo access detailed company insights
Xbrane Biopharma AB (publ), a biotechnology company, engages in the development, manufacture, and sale of biosimilars. The company offers Ximluci, a ranibizumab biosimilar used for the treatment of various eye diseases, including wet form of age-related macular degeneration, diabetic macular edema, diabetic retinopathy, retinal vein occlusion, and... Read More
